Kitahiroshima, Japan

Noriko Tabayashi



Average Co-Inventor Count = 6.7

ph-index = 1


Location History:

  • Hokkaido, JP (2020)
  • Kitahiroshima, JP (2015 - 2022)

Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Noriko Tabayashi: Innovator in Medical Science

Introduction

Noriko Tabayashi is a prominent inventor based in Kitahiroshima, Japan. She has made significant contributions to the field of medical science, particularly in the development of vaccines and therapeutic agents. With a total of 4 patents to her name, her work has the potential to impact public health positively.

Latest Patents

One of her latest inventions is a malaria transmission-blocking vaccine. This vaccine utilizes an immunogenic protein specifically expressed in the oocyst stage of malaria parasites. It aims to provide an oral transmission-blocking vaccine capable of immunizing various animals involved in the malaria infectious cycle. Another notable patent is related to the therapeutic effect of oral interferon alpha administration on chronic intractable external otitis. This invention offers a composition that can prevent and treat chronic external otitis, demonstrating immediate and sustained effects.

Career Highlights

Throughout her career, Noriko has worked with reputable organizations such as Hokusan Co. Ltd and the National Institute of Advanced Industrial Science and Technology. Her experience in these institutions has allowed her to develop innovative solutions to pressing medical challenges.

Collaborations

Noriko has collaborated with notable colleagues, including Takeshi Matsumura and Uiko Kagaya. These partnerships have contributed to her success in the field of medical innovation.

Conclusion

Noriko Tabayashi's work exemplifies the spirit of innovation in medical science. Her contributions through her patents have the potential to improve health outcomes and advance research in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…